Detection of EETs and HETE-generating cytochrome P-450 enzymes and the effects of their metabolites on myometrial and vascular function

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 3, 2009, Pages

  Pearson, Timothy ^a,b   Warren, Averil Y ^a   Barrett, David A ^a   Khan, Raheela N ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Epoxyeicosatrienenoic acids; Hydroxyeicosatetrenoic acids; Labor; Pregnancy; Uterus

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; BRADYKININ; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2J2; CYTOCHROME P450 4A; CYTOCHROME P450 4A11; CYTOCHROME P450 4A22; CYTOCHROME P450 4F3; EPOXYICOSATRIENOIC ACID; GLIBENCLAMIDE; HYDROXYICOSATETRAENOIC ACID; PAXILLINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IC 50; LABOR ONSET; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; THIRD TRIMESTER PREGNANCY; UTERUS; UTERUS CONTRACTILITY; UTERUS RELAXATION; VASOCONSTRICTION;

8,11,14-EICOSATRIENOIC ACID; BLOOD VESSELS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LABOR, OBSTETRIC; MYOMETRIUM; PREGNANCY; UTERINE CONTRACTION;

EID: 69049120448     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00227.2009     Document Type: Article

References (54)

1. Aaronson PI, Sarwar U, Gin S, Rockenbauch U, Connolly M, Tillet A, Watson S, Liu B, Tribe RM. A role for voltage-gated, but not Ca2+-activated, K+ channels in regulating spontaneous contractile activity in myometrium from virgin and pregnant rats. Br J Pharmacol 147: 815-824, 2006.
2. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, Platonov M, Koshal A, Hashimoto K, Campbell WB, Falck JR, Michelakis ED. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation 107: 769-776, 2003.
3. Ashworth JR, Warren AY, Baker PN, Johnson IR. A comparison of endothelium-dependent relaxation in omental and myometrial resistance arteries in pregnant and nonpregnant women. Am J Obstet Gynecol 175: 1307-1312, 1996.
4. Behm DJ, Ogbonna A, Wu C, Burns-Kurtis CL, Douglas SA. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation. J Pharmacol Exp Ther 328: 231-239, 2009.
5. Bennett PR, Elder MG, Myatt L. The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 33: 837-844, 1987.
6. Bethin KE, Nagai Y, Sladek R, Asada M, Sadovsky Y, Hudson TJ, Muglia LJ. Microarray analysis of uterine gene expression in mouse and human pregnancy. Mol Endocrinol 17: 1454-1469, 2003.
7. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
8. Campbell WB, Harder DR. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res 84: 484-488, 1999.
9. Capdevila JH, Falck JR. The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 285: 571-576, 2001.
10. Chanrachakul B, Pipkin FB, Khan RN. Contribution of coupling between human myometrial β2-adrenoreceptor and the BK(Ca) channel to uterine quiescence. Am J Physiol Cell Physiol 287: C1747-C1752, 2004.
11. Di Augustine RP, Fouts JR. The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450. Biochem J 115: 547-554, 1969.
12. Earley S, Heppner TJ, Nelson MT, Brayden JE. TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels. Circ Res 97: 1270-1279, 2005.
13. Enayetallah AE, French RA, Thibodeau MS, Grant DF. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52: 447-454, 2004.
14. Fissithaler B, Popp R, Kiss L, Potente M, Harder ER, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
15. Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, Fleming I. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension 36: 270-275, 2000.
16. Fisslthaler B, Popp R, Michaelis UR, Kiss L, Fleming I, Busse R. Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase. Hypertension 38: 1427-1432, 2001.
17. Frisbee JC, Roman RJ, Krishna UM, Falck JR, Lombard JH. Relative contributions of cyclooxygenase- and cytochrome P450 omega-hydroxylase-dependent pathways to hypoxic dilation of skeletal muscle resistance arteries. J Vasc Res 38: 305-314, 2001.
18. Gaedigk A, Baker DW, Totah RA, Gaedigk R, Pearce RE, Vyhlidal CA, Zeldin DC, Leeder JS. Variability of CYP2J2 expression in human fetal tissues. J Pharmacol Exp Ther 319: 523-532, 2006.
19. Garcia-Martin E, Martinez C, Ladero JM, Agundez JA. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals. Mol Diagn Ther 10: 29-40, 2006.
20. Garcia-Martin E, Martinez C, Ladero JM, Gamito FJ, Agundez JA. High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population. Eur J Clin Pharmacol 57: 47-49, 2001.
21. Gebremedhin D, Lange AR, Narayanan J, Aebly MR, Jacobs ER, Harder DR. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J Physiol 507: 771-781, 1998.
22. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 371: 75-84, 2008.
23. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI. Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry (Mosc) 33: 1743-1752, 1994.
24. Gonzalez E, Jawerbaum A, Novaro V, Gimeno MA. Influence of epoxyeicosatrienoic acids on uterine function. Prostaglandins Leukot Essent Fatty Acids 56: 57-61, 1997.
25. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, Roman R. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol Heart Circ Physiol 266: H2098-H2107, 1994.
26. Jakobsson M, Gissler M, Paavonen J, Tapper AM. The incidence of preterm deliveries decreases in Finland. BJOG 115: 38-43, 2008.
27. + channels in nonlabor and labor human uterine myocytes. Am J Physiol Cell Physiol 273: C1721-C1731, 1997.
28. Khan RN, Smith SK, Morrison JJ, Ashford ML. Properties of large-conductance K+ channels in human myometrium during pregnancy and labour. Proc Biol Sci 251: 9-15, 1993.
29. Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. Br Med J 332: 937-939, 2006.
30. Larsen BT, Miura H, Hatoum OA, Campbell WB, Hammock BD, Zeldin DC, Falck JR, Gutterman DD. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition. Am J Physiol Heart Circ Physiol 290: H491-H499, 2006.
31. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem 275: 4118-4126, 2000.
32. Marlow N. Neurocognitive outcome after very preterm birth. Arch Dis Child Fetal Neonatal Ed 89: F224-228, 2004.
33. Marlow N, Wolke D, Bracewell MA, Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 352: 9-19, 2005.
34. Matsubara S, Yamamoto S, Sogawa K, Yokotani N, Fujii-Kuriyama Y, Haniu M, Shively JE, Gotoh O, Kusunose E, Kusunose M. cDNA cloning and inducible expression during pregnancy of the mRNA for rabbit pulmonary prostaglandin omega-hydroxylase (cytochrome P-450p-2). J Biol Chem 262: 13366-13371, 1987.
35. Morrison JJ, Ashford ML, Khan RN, Smith SK. The effects of potassium channel openers on isolated pregnant human myometrium before and after the onset of labor: potential for tocolysis. Am J Obstet Gynecol 169: 1277-1285, 1993.
36. Nelson DR. Cytochrome P450 nomenclature, 2004. Methods Mol Biol 320: 1-10, 2006.
37. Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123: 369-375, 2003.
38. Oltman CL, Weintraub NL, VanRollins M, Dellsperger KC. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 83: 932-939, 1998.
39. Petrini JR, Dias T, McCormick MC, Massolo ML, Green NS, Escobar GJ. Increased risk of adverse neurological development for late preterm infants. J Pediatr 154: 169-176, 2009.
40. Powell WS. Distribution of prostaglandin omega-hydroxylases in different tissues. Prostaglandins 19: 701-710, 1980.
41. Quayle JM, Standen NB. KATP channels in vascular smooth muscle. Cardiovasc Res 28: 797-804, 1994.
42. Randriamboavonjy V, Kiss L, Falck JR, Busse R, Fleming I. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. Cardiovasc Res 65: 487-494, 2005.
43. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
44. Roman RJ, Maier KG, Sun CW, Harder DR, Alonso-Galicia M. Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 27: 855-865, 2000.
45. Saeed SA, Mitchell MD. Formation of arachidonate lipoxygenase metabolites by human fetal membranes, uterine decidua vera and placenta. Prostaglandins Leukot Med 8: 635-640, 1982.
46. Seliskar M, Rozman D. Mammalian cytochromes P450 - importance of tissue specificity. Biochim Biophys Acta 1770: 458-466, 2007.
47. Song M, Zhu N, Olcese R, Barila B, Toro L, Stefani E. Hormonal control of protein expression and mRNA levels of the MaxiK channel alpha subunit in myometrium. FEBS Lett 460: 427-432, 1999.
48. Wetzka B, Schafer W, Scheibel M, Nusing R, Zahradnik HP. Eicosanoid production by intrauterine tissues before and after labor in short-term tissue culture. Prostaglandins 45: 571-581, 1993.
49. Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271: 3460-3468, 1996.
50. Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059-36062, 2001.
51. Zhang JH, Pearson T, Matharoo-Ball B, Ortori CA, Warren AY, Khan R, Barrett DA. Quantitative profiling of epoxyeicosatrienoic, hydroxyeicosatetraenoic, and dihydroxyeicosatetraenoic acids in human intrauterine tissues using liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem 365: 40-51, 2007.
52. Zhang Y, Oltman CL, Lu T, Lee HC, Dellsperger KC, VanRollins M. EET homologs potently dilate coronary microvessels and activate BK(Ca) channels. Am J Physiol Heart Circ Physiol 280: H2430-H2440, 2001.
53. Zhou XB, Wang GX, Ruth P, Huneke B, Korth M. BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 279: C1751-C1759, 2000.
54. + channel in renal arterioles. Am J Physiol Regul Integr Comp Physiol 270: R228-R237, 1996.